Download PDF
ZFA (Stuttgart) 2003; 79(5): 238-243
DOI: 10.1055/s-2003-40715
Prävention

© Georg Thieme Verlag Stuttgart · New York

Compliance: Neue Positionen am Beispiel des Diabetes mellitus

Compliance: New concepts of Diabetes mellitusJ. Möbes
Further Information

Publication History

Publication Date:
21 July 2003 (online)

    Permissions and Reprints

Zusammenfassung

Die Literatur der letzten 30 Jahre zeigt ein Umdenken im Problembereich der Patientencompliance. Das Verständnis von Compliance veränderte sich vom hierarchischen Ansatz hin zum individuellen Aushandeln von Therapieregimen auf der Basis der jeweiligen individuellen Situation des Patienten. Zentrale Begriffe heute sind: Lebensqualität, Selbstmanagement und Arzt-Patienten-Beziehung. Es wird hierzu ein Literaturüberblick gegeben.

Summary

Literature of the recent 30 years shows a change in the concept of patient compliance. The understanding of compliance shifted from a hierarchical base to a patient centered approach. The central topics today are: quality of life, self-management, patient-doctor relationship. A literature review is given.

Schlüsselwörter

Compliance - Diabetes mellitus - Lebensqualität - Selbstmanagement - Arzt-Patienten-Beziehung

Key words

Compliance - Diabetes mellitus - quality of life - self-management and patient-doctor relationship

Literatur

  • 1 American Association of Retired Persons(AARP) . The economics of Non-Compliance. Pharmacoressources.  1995;  4
    Google Scholar
  • 2 Berger M. et al. . Diabetesbehandlung in unserer Praxis: Behandlungs- und Schulungsprogramm für Typ2 Diabetiker, die (nicht) Insulin spritzen.  Deutscher Ärzteverlag. 1987; 
    PubMedGoogle Scholar
  • 3 Berger M. Selbsttherapie bei Typ 2 Diabetes mellitus. Compliance und Selbstmanagement (Petermann F).  Hogrefe. 1998;  161-186
    PubMedGoogle Scholar
  • 4 Boehm S. et al. . Behavioral analysis and behavioural strategies to improve self-management of type 2 diabetes.  Clin Nurs Res. 1993;  2 327-44
    CrossrefPubMedGoogle Scholar
  • 5 Brown JB. et al. . The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus.  Family Practice. 2002;  9 344-349
    PubMedGoogle Scholar
  • 6 Chiechanowski PS. et al. . The patient-provider relationship: attachment theory and adherence to treatment in diabetes.  Am J Psychiatry. 2001;  158 29-35
    CrossrefPubMedGoogle Scholar
  • 7 de Grauw WJC. et al. . Insulin therapy in poorly controlled type 2 diabetic patients: does it effect quality of life.  British Journal of General Practice. 2001;  51 527-532
    PubMedGoogle Scholar
  • 8 Haehn KD. Compliance - Zauberwort oder Selbstverständlichkeit? H.  Heuser-Schreiber(Hrsg.), Arzt und Patient im Gespräch, Basel: Karger. 1982; 
    PubMedGoogle Scholar
  • 9 Haisch J. et al. . Effektivität und Effizienz ambulanter Diabetikerschulungen;.  Dtsch Med Wschr. 2000;  125 171-176
    PubMedGoogle Scholar
  • 10 Hasford J. et al. . Vergleichende Analyse und Bewertung von Methoden zur Erfassung der Compliance.  Compliance und Selbstmanagement (Petermann F) Hogrefe. 1998;  21-44
    PubMedGoogle Scholar
  • 11 Haynes RB. Determinants of Compliance, the diseases and the mechanics of treatment.  RB Haynes, DW Taylor & DL Sackett (Eds.): Compliance in health care Baltimore  Johns Hopkins University Press. 1979;  49-62
    PubMedGoogle Scholar
  • 12 Heisler M. et al. . The relative importance of physician communication, participatory decision making, and patient understanding in diabetes self-management.  J Gen Intern Med. 2002;  17 243-248
    CrossrefPubMedGoogle Scholar
  • 13 Kjellgren KJ. et al. . Taking antihypertensive medication - controlling or cooperating with patients?.  Int J of Cardiology. 1995;  47 257-268
    PubMedGoogle Scholar
  • 14 Kronsbein P. et al. . Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes.  Lancet. 1988;  1407-1411
    PubMedGoogle Scholar
  • 15 Lotz-Rambaldi W. et al. . Typ 2 Diabetes im Alter - ein Compliance-Problem?.  Compliance und Selbstmanagement (Petermann F), Hogrefe. 1998;  187-200
    PubMedGoogle Scholar
  • 16 Mäenpää H. et al. . Minimal doses of Digoxin: a new marker for compliance to medication.  European Heart Journal. 1987;  8 31-37
    PubMedGoogle Scholar
  • 17 McDonald HP. et al. . Interventions to enhance patient adherence to medication prescriptions.  JAMA. 2002;  22 2868-2879
    PubMedGoogle Scholar
  • 18 Nadeau J. et al. . Teaching subjects with type 2 diabetes: How to incorporate sugar choices in their daily meal plan promotes dietry compliance and does not deteriorate metabolic profile.  Diabetes Care. 2001;  24 222-227
    PubMedGoogle Scholar
  • 19 Petermann F. Compliance und Selbstmanagement.  Hogrefe. 1998;  9-18
    PubMedGoogle Scholar
  • 20 Pullar T. et al. . Time to stop counting tablets?.  Clinical Pharmacology and Therapeutics. 1989;  46 163-168
    PubMedGoogle Scholar
  • 21 Russell E. et al. . Moving From Compliance To Adherence Is Not Enough.  Diabetes Care. 1999;  22 2090-2091
    PubMedGoogle Scholar
  • 22 Surwitt RS. et al. . Stress Management improves long-term Glycemic control in type 2 Diabetes.  Diabetes Care. 2002;  25 30-34
    PubMedGoogle Scholar
  • 23 Warschburger P. Lebensqualität und Compliance - die Sichtweise der Patienten.  Compliance und Selbstmanagement (Petermann F). Hogrefe. 1998;  103-129
    PubMedGoogle Scholar
  • 24 Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance.  The Am J of Hospital Pharmacists. 1991;  48 1978-1988
    PubMedGoogle Scholar
  • 25 Glasgow RE. Compliance to diabetes regimes - Conceptualization, complexity, and determinants. Patient Compliance in medical practice and clinical trials.  JA Cramer (Eds) New York: Ravens Press. 1991;  209-224
    PubMedGoogle Scholar
  • 26 Ickovics JR, Meisler AW. Adherence in AIDS clinical trials: a framework for clinical research and clinical care.  J of Clin Epidemiology. 1997;  50 385-391
    PubMedGoogle Scholar
  • 27 Melnikow J, Kiefe C. Patient compliance and medical research: issues in methodology.  J of Gen Int Med. 1994;  9 96-105
    PubMedGoogle Scholar
  • 28 Morris LS, Schulz RM. Medication Compliance: the patient's perspective.  Clinical Therapeutics. 1993;  15 593-606
    PubMedGoogle Scholar
  • 29 Rand CS. et al. . Metered-dose inhaler adherence in a clinical trial.  Am Review of Respiratory Disease. 1992;  146 1559-1564
    PubMedGoogle Scholar
  • 30 Rand CS, Wise RA. Measuring adherence to asthma medication regimens.  Am J of respiratory and Critical Care Medicine. 1994;  49 69-76
    PubMedGoogle Scholar
  • 31 Rudd P. The measurement of compliance: medication taking. Developmental aspects of health compliance behavior.  Krasnegor, Epstein, Johnson, Yaffe (Eds.) Hillsdale: Lawrence Erlbaum. 1993;  185-213
    PubMedGoogle Scholar
  • 32 Sawicki PT. et al. . Strukturoptimierung der antihypertensiven Therapie.  Dtsch Ärzteblatt. 1993;  90 1736-1741
    PubMedGoogle Scholar
  • 33 Spilker B. Methods of assessing and improving patient compliance in clinical trials. Patient compliance in medical practice and clinical trials.  Cramer & Spilker (Eds.) New York: Raven Press. 1991;  37-56
    PubMedGoogle Scholar
  • 34 Stephenson BJ. et al. . Is this patient taking the treatment as prescribed?.  J of Am Med Association. 1993;  269 2779-2781
    PubMedGoogle Scholar

Dr. med. Jette Möbes

Höhenweg 1, 58553 Halver

Email: j.moebes@tiscali.de

Zur Person

Dr. med. Jette Möbes

1999 Fachärztin für Allgemeinmedizin, dann zwei Jahre Mitarbeit in der Chirurgie im Johanniter Krankenhaus Radevormwald, 2002 Abteilung für Allgemeinmedizin der Universität Düsseldorf, seit Februar 2003 interdisziplinäre Ambulanz am Johanniter Krankenhaus Radevormwald.

      >